L-Glutamine — Research Profile

Glutamine is the primary fuel for intestinal epithelial cells and supports tight junction integrity. ^[3] Clinical studies show it can preserve intestinal permeability during stress. For "leaky gut" (increased intestinal permeability), 5-10 g/day is commonly recommended by integrative practitioners, with supporting evidence from surgical and ICU populations. ^[7]

Glutamine is popular among bodybuilders, but evidence for direct muscle-building effects in healthy, well-fed individuals is weak. Your body makes enough glutamine under normal conditions. It may be more beneficial during very intense training periods, caloric restriction, or when training volume causes immune suppression.

Yes. Glutamine is a naturally abundant amino acid and has been used safely at 5-20 g/day in clinical trials lasting weeks to months. It is generally recognized as safe (GRAS). The only population that should exercise caution is those with liver disease (hepatic encephalopathy risk) or seizure disorders.

L-glutamine is the form used in essentially all clinical research and is the sole ingredient in the FDA-approved product, so free-form L-glutamine powder or capsules are the evidence-backed choice. Bonded "glutamine peptides" such as alanyl-glutamine are marketed as more stable in liquid, but they have not been shown to outperform plain L-glutamine for oral supplementation.

The strongest evidence is for reducing the frequency of painful vaso-occlusive crises in sickle cell disease, the basis for its FDA approval in patients 5 and older. Controlled trials also support benefit for radiation-related oral mucositis and show enhanced salivary immunity with fewer upper-respiratory infections in intensively training combat-sport athletes. Notably, a randomized trial in head and neck cancer found no survival benefit (80% vs 72% five-year survival, not statistically significant), and evidence for muscle recovery or general immunity in healthy adults remains weak and inconsistent.

There is no single daily dose; the amount depends on the goal. The FDA-approved sickle cell regimen is weight-based and taken twice daily: 5 g per dose (10 g/day) under 30 kg, 10 g per dose (20 g/day) for 30 to 65 kg, and 15 g per dose (30 g/day) above 65 kg. The separate FDA-approved short bowel syndrome protocol uses 5 g six times daily (30 g/day) for up to 16 weeks, whereas common fitness doses near 5 g/day have little efficacy data behind them.

In the sickle cell trials each dose was taken twice daily at evenly spaced times, mixed into 8 oz (240 mL) of a beverage or 4 to 6 oz of soft food, without tying it to a specific hour of the day. No study has directly compared times of day for a better outcome, so scheduling is driven by even spacing and tolerability rather than a proven optimal window.

In controlled sickle cell trials the most common reactions (incidence >10%) were constipation (21%), nausea (19%), headache (18%), abdominal pain (17%), cough (16%), pain in an extremity (13%), back pain (12%), and chest pain (12%), most only modestly above placebo rates. Allergic reactions such as rash, itching, hives, or swelling of the face, lips, or tongue are also possible and warrant stopping the product.

Glutamine has few documented drug interactions, but Memorial Sloan Kettering flags two worth noting: it may reduce the ammonia-lowering effect of lactulose and may increase tumor retention of methotrexate. Because it is otherwise poorly characterized against most prescription drugs, prescribers still advise disclosing all medications and supplements before starting it.

The clearest candidates are people aged 5 and older with sickle cell disease who want to reduce painful crises, for whom prescription L-glutamine is FDA-approved. It may also be considered under medical supervision as adjunctive care for cancer patients with treatment-induced oral mucositis, whereas healthy adults taking it for muscle growth or general immunity are unlikely to see a meaningful effect given the weak evidence in that setting.

L-glutamine is not a fast-acting supplement: its one rigorously proven benefit, reducing the frequency of sickle cell pain crises, was measured over a 48-week trial of twice-daily dosing, so results accrued over months rather than days. For the popular fitness and immune uses, no reliable time-to-effect exists because those applications lack consistent controlled evidence.

In the pivotal sickle cell trials, prescription L-glutamine (Endari) was taken twice daily for 48 weeks with an adverse-event profile close to placebo, and a separate randomized trial of a daily allulose-amino glutamine formulation reported acceptable tolerability. Continuous use beyond roughly a year has not been well characterized in controlled studies, so long-term safety at supplement doses remains only partly established.

No tolerable upper intake level has been established for supplemental glutamine, and clinical protocols use large amounts without a defined toxic threshold: up to 15 g twice daily (30 g/day) for sickle cell disease and 5 g six times daily (30 g/day) for short bowel syndrome. Even so, gastrointestinal effects such as constipation (21% vs 18% on placebo in the sickle cell trials), nausea, and abdominal pain become more likely as the dose climbs.

There are no well-documented interactions between glutamine and common dietary supplements, though Memorial Sloan Kettering notes it can reduce the ammonia-lowering effect of lactulose and may increase tumor retention of methotrexate, so overlap with medications warrants clinician input. Glutamine has been studied inside perioperative blends with arginine and HMB and alongside probiotics for gut applications, but those trials test the combination rather than glutamine's independent contribution, so a co-supplement benefit for glutamine alone is not established.

Choose a product listing pure L-glutamine, the biologically active form used in research, rather than an unspecified "glutamine," and prefer one third-party tested for identity and contaminants since supplement-grade glutamine is not FDA-regulated for potency. The only form with regulatory oversight is the prescription product Endari, a pharmaceutical-grade L-glutamine powder supplied in fixed 5 g packets and dosed for sickle cell disease.